2023-12-09
AC-003 ODD Granted by FDA

2023-11-23
AC-201 first in human in China

2023-09-08
AC-201 IND Approval (NMPA)

2023-06-26
AC-201 first in human in AUS

2023-06-21
AC-101 IND Approval (NMPA)

2023-05-12
AC-201 clinical trial was approved (HREC)

2023-05-04
AC-003 clinical trial for GVHD was approved (NMPA)

2023-04-12
AC-101 first in human in AUS

2023-03-02
AC-101 clinical trial was approved (HREC)

2022-12-07
AC-101 apply for clinical trial in AUS

2022-10-26
AC-003 first in human in China

2022-8-4
AC-003 IND Approval (NMPA)

2022-5-1
AC-003 IND Filing to NMPA

2022-4-6
AC-003 first in human in the US

2021-12-23
AC-003 IND Approval (FDA)

2021-12-1
Round B Financing

2021-11-24
AC-003 IND Filing to FDA

2017-12-21
Found Accro Bioscience (Suzhou) Limited

2017-9
Round A Financing